Fasting Insulin
Males, Age 20-29
The median fasting insulin for US males aged 20-29 is 7.1 µU/mL (43 pmol/L), with 90% of the population falling between 2.6 µU/mL and 33.2 µU/mL.
NHANES 2017-March 2020 Pre-Pandemic 2017-2020 · Sample size: 265 participants · Unit: µU/mL
Percentile Distribution
Unit:
| Percentile | P5 | P10 | P25 | P50 | P75 | P90 | P95 |
|---|---|---|---|---|---|---|---|
| Value (µU/mL) | 2.6 | 3.2 | 4.2 | 7.1 | 14.9 | 25.4 | 33.2 |
| 95% CI | 2.3 | 2.6 | 3.5 | 5.6 | 10.6 | 22.2 | 26.8 |
| Percentile | Value (µU/mL) | 95% CI |
|---|---|---|
| P5 | 2.6 | 2.3 |
| P10 | 3.2 | 2.6 |
| P25 | 4.2 | 3.5 |
| P50 | 7.1 | 5.6 |
| P75 | 14.9 | 10.6 |
| P90 | 25.4 | 22.2 |
| P95 | 33.2 | 26.8 |
The 95% confidence interval (CI) is the range of values for the population percentile that are consistent with this sample, given how NHANES selected participants. It describes uncertainty in the percentile, not in any one person's result.
4.2 7.1 14.9
P25 P50 P75
P5 2.6 P95 33.2
Data and Methodology
- Dataset
- NHANES 2017-March 2020 Pre-Pandemic ( NHANES 2017-2020 2020 , Survey-weighted percentiles from fasting subsample)
- Survey years
- 2017-2020
- Measurement
- Measured by two-site immunoenzymometric assay on Tosoh AIA-900. How it was measured
- Sample size
- 265 participants
- Reference population
- US civilian non-institutionalized males aged 20-29 from NHANES 2017-March 2020. Includes the full population (not restricted to healthy individuals) to reflect the population distribution.
- Exclusion criteria
-
- Missing fasting insulin measurement (LBXIN)
- Missing or zero fasting sample weight (WTSAF)
- Age outside 20-29 range
- Notes
- Percentiles computed using the combined pre-pandemic fasting-subsample weight (WTSAFPRP). Fasting insulin measured as LBXIN in µU/mL from the fasting subsample. Corrected October 2026: the previous version of these figures counted 280 participants in this group, including 15 who did not meet the fasting requirement of 8 to under 24 hours.